BackgroundThe development of ghost cell glaucoma in patients with proliferative diabetic retinopathy (PDR) after intravitreous injection (IV) was rare. Here we reported a series of patients with PDR who received Intravitreous Ranibizumab (IVR) and developed ghost cell glaucoma and analyzed the potential factors that might be related to the development of ghost cell glaucoma.MethodsRetrospective case series study. The medical records of 71 consecutive eyes of 68 PDR patients who received vitrectomy after IVR from January 2015 to January 2017 were reviewed. The development of ghost cell glaucoma after IVR was recorded. Characteristics of enrolled patients were retrieved from their medical charts. Factors associated with ghost cell glaucoma were compared between eyes with the development of ghost cell glaucoma and eyes without the development of ghost cell glaucoma. Variables were further enrolled in a binary backward stepwise logistic regression model, and the model that had the lowest AIC was chosen.ResultsThere were 8 out of 71 eyes of the PDR patients developed ghost cell glaucoma after they received IVR. The interval between detection of elevation of intraocular pressure (IOP) and IV ranged from 0 to 2days. Among them, after IVR, there were two eyes had IOP greater than 30mmHg within 30min, four eyes showed normal IOP at 30min, and then developed ghost cell glaucoma within 1day, two eyes developed ghost cell glaucoma between 24 and 48h. The mean IOP was 46.58.0mmHg. All patients gained normal IOP after vitrectomy without medicine for lowering IOP. The presence of ghost cell glaucoma was associated with tractional retinal detachment (RR=4.60 [2.02 similar to 8.48], p=0.004) and fibrovascular membrane involving disk (RR=-3.57 [-7.59 similar to-0.92], p=0.03) (AIC=39.23, AUC=0.88) in a logistic regression model.Conclusion Attention to postoperative IOP should be paid to patients with PDR undergoing vitrectomy who receive a preoperative IV of anti-VEGF agents. PDR patients with tractional retinal detachment or fibrovasucular membrane involving optic disc are more likely to develop ghost cell glaucoma after IV.
第一作者机构:[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Tongren Hospital, Capital Medical University, No1. Dongjiaominxiang street, Dongcheng District, Beijing 100730, China
通讯作者:
推荐引用方式(GB/T 7714):
Xu Jun,Zhao Meng,Li Ji Peng,et al.Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy[J].BMC OPHTHALMOLOGY.2020,20(1):doi:10.1186/s12886-020-01422-z.
APA:
Xu, Jun,Zhao, Meng,Li, Ji Peng&Liu, Ning Pu.(2020).Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy.BMC OPHTHALMOLOGY,20,(1)
MLA:
Xu, Jun,et al."Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy".BMC OPHTHALMOLOGY 20..1(2020)